Polio Clinical Trial
Official title:
Evaluation of TaqMan Array Card for Environmental Surveillance of Polio Virus and Antimicrobial Resistance Genes
This study will be used to develop a tool to streamline poliovirus environmental surveillance for the polio endgame and to provide a tool for detecting polio in places where there is no capacity to carry out the gold standard culture-based detection.
This environmental surveillance tool will also include antimicrobial resistance (AMR) genes to describe resistome profile in environmental samples and to better inform us of the potential risks of exposure to these environments ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00772369 -
Retrospective Survey of Safety of Fourth Dose Pentacel® in Children
|
Phase 4 | |
| Completed |
NCT00401531 -
Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants
|
Phase 3 | |
| Completed |
NCT00772928 -
Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™
|
Phase 3 | |
| Completed |
NCT00254917 -
Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines
|
Phase 4 | |
| Completed |
NCT04576910 -
Immunogenicity and Safety of the Booster Dose of Polio Vaccine With Different Primary Sequential Schedules in China
|
Phase 4 | |
| Completed |
NCT04264546 -
Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (Phase Ib)
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT06114810 -
Immunogenicity of Novel Oral Poliovirus Vaccine Type 2 (nOPV2), bOPV and IPV
|
Phase 4 | |
| Completed |
NCT01475539 -
Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine
|
Phase 4 | |
| Completed |
NCT01244464 -
A Study of the Safety of IMOVAX Polio™ in China
|
Phase 4 | |
| Completed |
NCT00255047 -
Safety and Immune Response of Different Pediatric Combination Vaccines.
|
Phase 3 | |
| Recruiting |
NCT05850364 -
A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine
|
Phase 3 | |
| Completed |
NCT00662870 -
Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine
|
Phase 3 | |
| Completed |
NCT03147560 -
Immunogenicity and Safety Evaluation of Different Sequential Immunization Strategies by Sabin IPV and bOPV in Chinese Infants
|
Phase 4 | |
| Completed |
NCT05083039 -
Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19
|
||
| Active, not recruiting |
NCT00932269 -
Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease
|
Phase 0 | |
| Completed |
NCT03922061 -
Evaluation of Safety, Reactogenicity and Immunogenicity of Fractional-dose Inactivated Polio Vaccine (fIPV) Given Intradermally With Double Mutant Enterotoxigenic Escherichia Coli Heat Labile Toxin (dmLT) Adjuvant
|
Phase 1 | |
| Completed |
NCT00348387 -
Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV
|
Phase 3 | |
| Not yet recruiting |
NCT06460545 -
Phase IV Study of Concomitant Administration of the sIPV and HepA
|
Phase 4 | |
| Active, not recruiting |
NCT01908114 -
To Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in Pakistan
|
Phase 4 | |
| Completed |
NCT01389687 -
Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan
|
Phase 3 |